Bioray Biotech Co (ROCO:7561) ROCE %: 7.07% (As of Dec. 2025)


ROCO:7561 Bioray Biotech Co Ltd ROCO:7561
83 GF Score
Price NT$18.05
GF Value NT$29.46
Valuation Significantly Undervalued
View Full Analysis

What is Bioray Biotech Co ROCE %?

Bioray Biotech Co ROCO:7561 -3.48% 83 ROCE % is 7.07% as of Dec. 2025. GuruFocus rates ROCO:7561 with a GF Score™ of 83/100 and a GF Value™ of NT$29.46 (Significantly Undervalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bioray Biotech Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 7.07%.

Bioray Biotech Co  (ROCO:7561) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bioray Biotech Co ROCE % Related Terms

Bioray Biotech Co ROCE % Historical Data

* Premium members only.

The historical data trend for Bioray Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioray Biotech Co ROCE % Chart

Bioray Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only -1.32 0.44 -2.50 0.54 8.41

Bioray Biotech Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.50 -4.87 5.99 10.01 7.07
ROCO:7561
83GF Score
Bioray Biotech Co Ltd ROCO:7561
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioray Biotech Co ROCE % Calculation

Bioray Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=41.884/( ( (543.634 - 43.727) + (536.582 - 40.737) )/ 2 )
=41.884/( (499.907+495.845)/ 2 )
=41.884/497.876
=8.41 %

Bioray Biotech Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=34.588/( ( (523.971 - 41.174) + (536.582 - 40.737) )/ 2 )
=34.588/( ( 482.797 + 495.845 )/ 2 )
=34.588/489.321
=7.07 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.07% mean?
Bioray Biotech Co (ROCO:7561) has a ROCE % of 7.07% as of Dec. 2025.
Is Bioray Biotech Co's ROCE % too high?
Bioray Biotech Co's current ROCE % is 7.07%. The Drug Manufacturers industry median ROCE % is 7.01. Bioray Biotech Co's value of 7.07% is 0.9% above this industry median. Overall, Bioray Biotech Co has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioray Biotech Co's ROCE % compare to ZTS and UTHR?
Bioray Biotech Co's ROCE % of 7.07% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.01. Bioray Biotech Co's value of 7.07% is 0.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.01, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioray Biotech Co's current ROCE % of 7.07% is 0.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioray Biotech Co's current ROCE % is 7.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioray Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Bioray Biotech Co (ROCO:7561) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$29.46, compared to a current price of NT$18.05 — trading 38.7% below its estimated fair value. The current ROCE % is 7.07% and 0.9% above the Drug Manufacturers industry median of 7.01. Bioray Biotech Co's overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bioray Biotech Co (ROCO:7561), the current ROCE % is 7.07% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioray Biotech Co (ROCO:7561) Overvalued in 2026?

Based on GuruFocus' analysis, Bioray Biotech Co stock appears to be undervalued. The current stock price of NT$18.05 is trading 38.7% below its estimated GF Value™ of NT$29.46. GuruFocus considers Bioray Biotech Co to be Significantly Undervalued.

Key valuation signals for ROCO:7561:

  • ROCE %: 7.07%
  • GF Value™: NT$29.46 vs. price of NT$18.05 (38.7% below fair value)
  • GF Score™: 83/100
  • Industry Position: 0.9% above the Drug Manufacturers median

No single metric tells the full story. See the ROCO:7561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioray Biotech Co Business Description

Address No. 1, Dali 2nd Road, Southern Science Park, Shanhua District, Tainan, TWN, 90846
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations.
83GF Score

Get the complete analysis for ROCO:7561

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.05
Price
NT$29.46
GF Value